Panagora Asset Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-5,501
| Closed | -$76K | – | 2523 |
|
|
2018
Q2 | $76K | Sell |
5,501
-6,739
| -55% | -$93.1K | ﹤0.01% | 1930 |
|
|
2018
Q1 | $111K | Buy |
+12,240
| New | +$111K | ﹤0.01% | 1829 |
|
|
2017
Q4 | – | Sell |
-250,421
| Closed | -$353K | – | 2401 |
|
|
2017
Q3 | $353K | Sell |
250,421
-67,435
| -21% | -$95.1K | ﹤0.01% | 1473 |
|
|
2017
Q2 | $477K | Buy |
317,856
+181,722
| +133% | +$273K | ﹤0.01% | 1366 |
|
|
2017
Q1 | $350K | Hold |
136,134
| – | – | ﹤0.01% | 1476 |
|
|
2016
Q4 | $347K | Hold |
136,134
| – | – | ﹤0.01% | 1570 |
|
|
2016
Q3 | $421K | Buy |
136,134
+64,734
| +91% | +$200K | ﹤0.01% | 1505 |
|
|
2016
Q2 | $229K | Buy |
71,400
+3,295
| +5% | +$10.6K | ﹤0.01% | 1621 |
|
|
2016
Q1 | $211K | Buy |
+68,105
| New | +$211K | ﹤0.01% | 1635 |
|
|
2013
Q3 | – | Sell |
-1,483
| Closed | -$19K | – | 2406 |
|
|
2013
Q2 | $19K | Buy |
+1,483
| New | +$19K | ﹤0.01% | 2191 |
|